Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS

Neurol Neuroimmunol Neuroinflamm. 2018 Jul 10;5(5):e479. doi: 10.1212/NXI.0000000000000479. eCollection 2018 Sep.

¹ Department of Neurology (F.S., M.K., L.H., A.M.), Charité-Universitätsmedizin Berlin; Institute of Neuropathology (I.M.), Universitätsmedizin Göttingen, Göttingen, Germany; Institute of Neuropathology (H.R.), Charité-Universitätsmedizin Berlin, Institute of Neuroradiology (E.S.), Charité-Universitätsmedizin Berlin; Department of Neurosurgery (S.W.), Charité-Universitätsmedizin Berlin; NeuroCure Clinical Research Center (A.M.), Charité-Universitätsmedizin Berlin; and Center for Stroke Research Berlin (F.S., A.M.), Charité-Universitätsmedizin Berlin, Germany.

No abstract available